<div class="content-intro"><p>For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.
</p> <p>Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists.
With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.
</p> <p>Corcept is headquartered in Redwood City, California.
To learn more, visit <a href=" is seeking a Director, Medical Affairs DACH to lead all medical affairs activities across Germany, Austria, and Switzerland.
Reporting to the DACH General Manager with a dotted-line relationship to the Senior Director, Medical Affairs Europe, role will serve as the DACH senior medical authority for the affiliate, driving medical strategy, providing leadership to cross-functional partners, and ensuring alignment between European priorities and local execution while bringing DACH-specific insights to inform regional decision-making.
</p> <p><strong>.